SSA
PVLA

Schonfeld Strategic Advisors’s Palvella Therapeutics PVLA Stock Holding History

Schonfeld Strategic Advisors’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,195
Closed -$532K – 3088
2022
Q1 		$532K Buy
2,195
+1,076
+96% +$283K ﹤0.01% 1322
2021
Q4 		$338K Buy
+1,119
New +$358K ﹤0.01% 1464
2021
Q3 		– Sell
-137
Closed -$42K – 2530
2021
Q2 		$42K Buy
+137
New +$30K ﹤0.01% 1878
2020
Q3 		– Sell
-669
Closed -$166K – 1722
2020
Q2 		$166K Buy
+669
New +$156K ﹤0.01% 1133
2020
Q1 		– Sell
-318
Closed -$92K – 1588
2019
Q4 		$92K Sell
318
-3,887
-92% -$1.08M ﹤0.01% 1212
2019
Q3 		$1.15M Buy
+4,205
New +$1.63M 0.03% 437
2019
Q2 		– Sell
-1,875
Closed -$503K – 1298
2019
Q1 		$503K Hold
1,875
– – 0.02% 688
2018
Q4 		$399K Sell
1,875
-3,125
-63% -$969K 0.02% 730
2018
Q3 		$2.24M Sell
5,000
-5,358
-52% -$2.33M 0.1% 260
2018
Q2 		$4.2M Sell
10,358
-25
-0.2% -$11.9K 0.23% 152
2018
Q1 		$5.67M Buy
10,383
+1,945
+23% +$1.2M 0.43% 54
2017
Q4 		$5.1M Sell
8,438
-625
-7% -$291K 0.42% 68
2017
Q3 		$4.18M Sell
9,063
-1,062
-10% -$453K 0.38% 80
2017
Q2 		$4.1M Buy
+10,125
New +$2.96M 0.42% 51

Other funds holding PVLA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Schonfeld Strategic Advisors's PVLA Position: Q2 2022 in Review

Schonfeld Strategic Advisors sold out of Palvella Therapeutics (PVLA) in Q2 2022, closing a stake of 2,195 shares — an estimated $532K sold.

Schonfeld Strategic Advisors first reported a position in PVLA in Q2 2017 and held it in 14 quarters. The position peaked at $5.67M in Q1 2018. 68 funds tracked by Wall St. Rank hold PVLA as of Q2 2022.

  • Schonfeld Strategic Advisors reported no remaining Palvella Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 2,195 Palvella Therapeutics shares in Q2 2022, an estimated $532K.
  • Schonfeld Strategic Advisors first reported a position in Palvella Therapeutics in Q2 2017 and held it in 14 quarters.
  • Schonfeld Strategic Advisors's Palvella Therapeutics position peaked at $5.67M in Q1 2018.
  • 68 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.